Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

Corstasis to present pivotal trial data on Bumetanide Nasal Spray at AHA 2024, highlighting safety, and efficacy. #AHA2024.

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

COLLEGE STATION, Texas — November is National Alzheimer's Awareness Month and now a new therapy out of Texas A&M University could treat Alzheimer's disease through a nasal spray. Seven million ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

A new therapy may delay Alzheimer’s disease progression by years ... In Alzheimer’s, microglia activate to cause inflammation and clear Alzheimer’s-related plaques from the brain. Credit: Neuroscience ...

Go to source) medication directly to the brain through the nasal route. TB that affects the ... Nanoscale (Royal Society of Chemistry). The new treatment method also helps reduce the inflammation ...

Permatan’s encapsulation technology is still relatively new, and there are few long-term studies on its effectiveness and ...